Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | ALPL | P05186 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.40 |
| ▸ | MEN1 | O00255 | 6/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.39 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.39 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.39 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.39 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.39 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11498378 | 0.92 | GAA (0.36) | ALDH1A1GAAHPGDHTTALPL | |
| SCHEMBL6400753 | 0.90 | ALDH1A1 (0.44) | ALDH1A1GAAHPGDHTTCYP1A2 | |
| SCHEMBL146503 | 0.84 | CYP1A2 (0.56) | ALDH1A1GAAHPGDHTTCYP1A2 | |
| SCHEMBL5160261 | 0.81 | CYP3A4 (0.35) | ALDH1A1GAAHPGDHTTALPL | |
| SCHEMBL334753 | 0.78 | ALDH1A1 (0.55) | ALDH1A1HPGDHTTCYP1A2CYP2C19 | |
| SCHEMBL553110 | 0.78 | ALDH1A1 (0.49) | ALDH1A1GAAHPGDHTTCYP1A2 | |
| SCHEMBL7977261 | 0.77 | CYP19A1 (0.72) | ALDH1A1CYP1A2CYP2C19CYP19A1KMT2A | |
| SCHEMBL10766886 | 0.74 | ALDH1A1 (0.44) | ALDH1A1GAAHPGDHTTCYP1A2 | |
| SCHEMBL9709253 | 0.74 | ALDH1A1 (0.58) | ALDH1A1GAAKMT2AMEN1RAB9A | |
| SCHEMBL30493502 | 0.74 | ALDH1A1 (0.58) | ALDH1A1GAAKMT2AMEN1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030149072-A1 | Substituted arylcycloalkanes, compositions containing them and use thereof | AVENTIS PHARMA S.A. (FR) | 2003-08-07 | — | — | US | claimed |
| US-6887904-B2 | Substituted arylcycloalkanes, compositions containing them and use thereof | AVENTIS PHARMA S. A. (FR) | 2005-05-03 | — | — | US | disclosed |
| US-20030149072-A1 | Substituted arylcycloalkanes, compositions containing them and use thereof | AVENTIS PHARMA S.A. (FR) | 2003-08-07 | — | — | US | disclosed |
| US-4543310-A | MULTILAYER-SUPPORT WITH PHOTOCONDUCTIVE LAYER CONTAINING AZINE CHARGE TRANSFER AGENT IN BINDER | OCE-NEDERLAND B.V. (NL) | 1985-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030149072-A1 | Substituted arylcycloalkanes, compositions containing them and use thereof | ABL1, MCL1, AHR | ALDH1A1 682/4885GAA 1425/4885HPGD 2895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.